99%+ Purity
COA Included
Sealed Vials
Tesamorelin
GHRH analog for visceral fat reduction
IGF-1 increase, visceral fat loss
Key Benefits
- Targeted visceral fat reduction support
- Natural growth hormone pathway activation
- IGF-1 production enhancement
- Lean muscle mass preservation
- Selective abdominal fat targeting
- Metabolic function optimization support
- Lipid profile improvement potential
Finally Target Stubborn Belly Fat Without Wrecking Your Hormones
Most fat loss approaches crash your natural hormone production and leave you weaker than when you started. Tesamorelin works through your body's existing growth hormone pathways to specifically target visceral fat—the dangerous kind around your organs—while preserving muscle and metabolic function. You get aggressive abdominal fat reduction without the hormonal disruption that makes most approaches unsustainable.
Growth hormone releasing hormone (GHRH) receptor activation / IGF-1 mediated lipolysis
About Tesamorelin
Tesamorelin is a synthetic analog of your body's natural growth hormone-releasing hormone that specifically stimulates endogenous GH production in normal physiological patterns. It preferentially targets visceral adipose tissue through enhanced IGF-1 signaling, promoting fat breakdown in abdominal deposits while supporting lean muscle preservation. The peptide works by binding to pituitary GHRH receptors to trigger natural growth hormone release rather than introducing external hormones.
Who It's For
Ideal for individuals dealing with stubborn abdominal fat accumulation who want targeted reduction without compromising their natural hormone balance. This approach is particularly valuable for those who have struggled with traditional fat loss methods that often sacrifice muscle mass and metabolic health. Tesamorelin integrates well into comprehensive body recomposition protocols where selective fat reduction and hormonal optimization are primary goals.
Research Background
Tesamorelin represents a significant advancement in peptide-based metabolic therapy, specifically designed to address visceral fat accumulation through the growth hormone axis. The peptide works by mimicking the body's natural growth hormone-releasing hormone (GHRH), binding to specific receptors in the pituitary gland to stimulate the release of endogenous growth hormone in physiological patterns. This approach preserves the body's natural regulatory mechanisms while achieving therapeutic effects. Research has focused on three primary areas: 1) selective visceral fat reduction through enhanced lipolysis in abdominal adipose tissue, 2) metabolic improvements including better insulin sensitivity and lipid profiles, and 3) preservation of lean muscle mass through IGF-1-mediated protein synthesis. The peptide's unique mechanism allows it to preferentially target visceral adipose tissue - the metabolically active fat around internal organs that contributes significantly to cardiovascular risk and insulin resistance. Unlike direct growth hormone administration, tesamorelin maintains natural pulsatile GH release patterns, potentially reducing side effects while achieving targeted fat loss. Current research continues to explore applications beyond HIV-associated lipodystrophy, investigating its potential in age-related visceral adiposity and broader metabolic disorders where selective fat reduction could provide clinical benefit.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 1 mg | |
Intermediate | 2 mg | |
Advanced | 1-2 mg | |
Maximum | 1.5 mg |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
17
168.0 mg needed ÷ 10 per vial
Total Investment
$1233
$72.50 per vial
Per Dose
0.40 mL
40 units on U-100 syringe
Doses per Vial
5
10 ÷ 2.00 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Educational Resources
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
Related Products
HGH 191 Frag
Human Growth Hormone for muscle, fat loss, and recovery
Ipamorelin
Selective GH secretagogue for clean GH pulses
WOLIVERINE BLEND - BPC-157 / TB-500
Healing blend for comprehensive tissue repair
CJC-1295 / Ipamorelin
CJC-1295 and Ipamorelin are designed for clients who want measurable performance, recovery, and longevity benefits—without crossing the line into hormone replacement or system shutdown. This is not synthetic HGH and it’s not a short-term hack. It’s a disciplined, physiology-first approach that restores the body’s own growth hormone signaling, which naturally declines with age, stress, poor sleep, and overtraining. CJC-1295 works upstream at the pituitary level, enhancing the quality, duration, and consistency of natural GH release, while Ipamorelin acts as a precision trigger—stimulating GH without the cortisol spikes, prolactin elevation, or hunger issues associated with older compounds. Together, they create smoother, more youthful GH pulses that the body actually knows how to use. From a client experience standpoint, this shows up where it matters: deeper, more restorative sleep; faster recovery between workouts or long workdays; improved fat metabolism; better skin and tissue quality; and a noticeable improvement in overall resilience. There’s no suppression of natural production, no dependency risk, and no hormonal rollercoaster—making it appropriate for long-term use and scalable protocols. For many clients, this stack becomes the foundation layer they build everything else on, because it improves how the body repairs, adapts, and recovers across the board. In short, this is growth hormone optimization for adults who play the long game—subtle, sustainable, and designed to deliver compounding returns over time.
CJC-1295 (No DAC)
GHRH analog for pulsatile GH release
Tesamorelin
$72.50